The In Vitro Assessment for Antimicrobial Activity program provides capability in a broad range of in vitro assessments to evaluate promising candidate countermeasures for antimicrobial activity against microbial pathogens and vectors, including those derived from clinical specimens.
This is one of several programs provided by NIAID's Division of Microbiology and Infectious Diseases to support infectious disease product developers.